DELHI, India -- Increase in the women’s population globally, rising healthcare expenditure, rising diabetic and obese population, increased consumption of tobacco and alcohol, exposure to x-ray and gamma radiations and estrogen-progestin therapy are the factors that are majorly contributing to the growth of breast cancer market. The market is likely to witness significant developments in the drugs and therapies for breast cancer treatment. In addition, there have been ongoing studies for the development of scintimammography for molecular breast imaging. Along with such developments, there are certain compounds under study to reduce the cases of breast cancer. However, the growth of breast cancer market is hindered by increased financial burden that it poses, and the adverse effects of aromatase inhibitors.

The research report,” Global Breast Cancer Market Report: 2015 Edition” reveals that the global breast cancer market is expanding as a result of increased awareness and health concerns of the people along with the ever continuing innovations in the drugs treatment and technologies. The breast cancer market is growing rigorously in the major economies including the U.S, Europe and the APAC region. The U.S. holds a major share in the breast cancer therapeutic market. The breast cancer drug market in Brazil has grown as a result of increase in the breast cancer cases, and increased use of targeted therapies due to new product launches. The market for mammography in Europe has also increased due to reducing prevalence of analog screening systems.

The report by Koncept Analytics provides comprehensive research and unbiased analysis of the current market performance and future outlook of the global and key regional breast cancer market – the U.S., Brazil, Europe and the APAC region. Following this, the report provides the reader with an outlook of the current status of the breast cancer market. It also encompasses a number of factors driving the growth of the global breast cancer market coupled with recent trends and challenges hindering the growth of the industry.

List of Charts

Types of Breast Cancer
Various Biopsy Methods
Global Oncology Drug Spending (2010-2014)
Global Oncology Spending By Region (2014)
Global Breast Cancer Predictive Diagnostic and Drug Technologies (2014 /2019E)
Global Breast Cancer Therapeutic Market (2014 /2018E)
Global Breast Cancer Market by Segments (2014E)
Cases of Breast Cancer in the U.S. by Stage
Breast Cancer Deaths by Age Group in the U.S.
The U.S. Breast Imaging Systems Market (2010-2016E)
The U.S. Digital Mammography Market (2010-2014)
Breast Cancer Therapeutic Market in Major Regions (2014E)
The U.S. Metastatic Breast Cancer Market Revenues (2011-2015E)
Breast Cancer Mortality Rates in Brazil (2008-2014E)
Brazil’s Breast Cancer Imaging Market (2011-2015E)
Brazilian Breast Cancer Drugs Market (2009-2014E)
APAC - Tomography Scanners per Million People (2014)
APAC - MRI Units per Million People (2014)
APAC - Mammography Units per Million Females (2014)
APAC Countries Therapeutic Market Share (2014E)
The European Breast Imaging Systems Market (2013-2018E)
The European Mammography Systems Market (2013-2018E)
European Metastatic Breast Cancer Market Revenues (2011-2015E)
Global Cigarettes Consumption (1910-2014)
Global Diabetic Population (2007-2014E)
Global Obese Population (2009-2014)
Global Healthcare Expenditure Per Capita (2009-2014E)
Global Female Population, Over 45 Years (2008-2014E)
Global Spending on Medicines (2007-2017E)
Net Income Comparison of Leading Companies (2014)
R&D Budgets of Top Companies (2014)
Johnson & Johnson Revenue by Business Segments (2014)
Johnson & Johnson’s Revenue and Net Income (2010-2014)
Hologic’s Revenue by Business Segment (2014)
Hologic’s Revenue and Net Income (2010-2014)
Roche’s Revenue by Business Segments (2014)
Roche’s Sales and Net Income (2010-2014)
Novartis Revenue by Business Segments (2014)
Novartis Revenues (2010-2014)
Siemens Revenue by Business Segments (2014)
Siemens Revenue and Net Income (2010-2014)

List of Tables

Stages of Breast Cancer
New Breast Cancer Cases and Deaths in the U.S. (2015E)
The U.S. MBC Market Revenue Model (2011-2015E)
Number of Deaths from Breast Cancer in Brazil
New Breast Cancer Cases and Deaths in the Europe (2014)
European MBC Market (2011-2015E)
CDK4/6 Inhibitors in Clinical Development
Side Effects of Aromatase Inhibitors Reported by Women
Comparison of Drugs Approved for HR Positive Breast Cancer
Comparison of P13 Kinases in Clinical Development
J&J’s R&D Expenses by Segment (2013 & 2014)

Note: Purchase by Section also Available

For more Information:

http://www.konceptanalytics.com/Researchreport/global-bre...

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID – vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:

http://www.konceptanalytics.com

Contact
Vikas Gupta
+91-9811715635
vikas@konceptanalytics.com